The Anal Pap Smear: Cytomorphology of squamous intraepithelial lesions.
BACKGROUND: Anal smears are increasingly being used as a screening test for anal squamous intraepithelial lesions (ASILs). This study was undertaken to assess the usefulness and limitations of anal smears in screening for ASILs. METHODS: The cytomorphological features of 200 consecutive anal smears collected in liquid medium from 198 patients were studied and findings were correlated with results of surgical biopsies and/or repeat smears that became available for 71 patients within six months. RESULTS: Adequate cellularity was defined as an average of 6 or more nucleated squamous cells/hpf. A glandular/transitional component was not required for adequacy. Dysplastic cells, atypical parakeratotic cells and bi/multinucleated cells were frequent findings in ASIL while koilocytes were infrequent. Smears from LSIL cases most frequently showed mildly dysplastic and bi/multinucleate squamous cells followed by parakeratotic cells (PK), atypical parakeratotic cells (APK), and koilocytes. HSIL smears contained squamous cells with features of moderate/severe dysplasia and many APKs. Features of LSIL were also found in most HSIL smears. CONCLUSIONS: In this study liquid based anal smears had a high sensitivity (98%) for detection of ASIL but a low specificity (50%) for predicting the severity of the abnormality in subsequent biopsy. Patients with cytologic diagnoses of ASC-US and LSIL had a significant risk (46-56%) of HSIL at biopsy. We suggest that all patients with a diagnosis of ASC-US and above be recommended for high resolution anoscopy with biopsy.
Arain
Shehla
S
Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. BoseS@cshs.org.
Walts
Ann E
AE
Thomas
Premi
P
Bose
Shikha
S
Lancet. 1998 Jun 20;351(9119):1833-9
9652666
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 15;14(5):415-22
9170415
Obstet Gynecol. 1990 Nov;76(5 Pt 1):857-9
2170888
Clin Infect Dis. 2002 Nov 1;35(9):1127-34
12384848
JAMA. 1999 May 19;281(19):1822-9
10340370
Acta Cytol. 1997 Jul-Aug;41(4):1167-70
9250316
JAMA. 1982 Apr 9;247(14):1988-90
7062503
Am J Obstet Gynecol. 2003 Jun;188(6):1393-400
12824968
Am J Obstet Gynecol. 2002 Oct;187(4):997-1001
12388995
JAMA. 2002 Apr 24;287(16):2114-9
11966386
Eur J Med Res. 2003 Apr 30;8(4):142-6
12765859
JAMA. 2002 Apr 24;287(16):2120-9
11966387
Semin Oncol. 2000 Aug;27(4):471-9
10950374
Mod Pathol. 1995 Apr;8(3):270-4
7617653
Diagn Cytopathol. 2001 Feb;24(2):79-81
11169883
Cytojournal. 2005 Feb 16;2(1):5
15715911
Cancer. 2004 Jul 15;101(2):270-80
15241823
Obstet Gynecol. 2002 Jun;99(6):1053-9
12052599
Lancet. 1994 Mar 12;343(8898):636-9
7906812
Cancer. 2004 Feb 25;102(1):19-26
14968414
Clin Infect Dis. 2004 May 15;38(10):1490-2
15156490
Dtsch Med Wochenschr. 2003 Sep 19;128(38):1957-62
14502448
Bull Cancer. 2003 May;90(5):405-11
12850763